Recently Huib Vriesendorp and Hal Drooglever Fortuyn issued a new publication, titled: The Chimeric Investigator, an Endangered Species. A Chimeric Investigator has both an MD ‘genotype’ and an Investigator ‘genotype’: a good starting point for translating serious problems of patients into an ‘experimental’ question. You can read the full article here.

We encourage other chimeric investigators to get in touch with Phase2Therapy. For this, please use our contact form and we’ll respond as soon as possible.